willow health semaglutide reviews vs HERS for Weight Loss GLP-1s Willow Weight Loss Review 2026:

After the SELECT trial cardiovascular indication for Wegovy (FDA approved March 2024) and the SURMOUNT-OSA approval for Zepbound (December 2024), Aetna added separate coverage pathways for those medical indications, which often bypass the obesity carve-outs

In the MASLD (metabolic dysfunction-associated steatotic liver disease) trial, retatrutide reduced liver fat by up to 82.4% at the 12mg dose level

Side-effect log General symptom tracking commonly includes nausea level, flushing, sleep changes, and any new symptoms

Cash, insurance, and co-pay cards accepted

Any weight loss therapy is most effective when combined with lifestyle changes like a balanced diet and regular exercise

However, this may vary from patient to patient